|
|
International Federation of Anthroposophical Medical Associations IVAAAnthroposophic medicine in brief: Facts and FiguresDistribution of anthroposophic medicineFrom its inception in 1920 to the present day, anthroposophic medicine has been able to develop well within the European member states, and has found increasing recognition both amongst the general public and in the academic world, as illustrated by the following data: Anthroposophic
medicinal products are prescribed by approximately 120.000 doctors (General
Practitioners and Specialists) in thirteen Member States (Austria, Belgium,
Denmark, Eire, Finland, France, Germany, Italy, Netherlands, Portugal, Spain,
Sweden, United Kingdom). Anthroposophic
medicine is practised in hospitals, clinics and other in-patients’ facilities
in Austria, Germany, Italy, Netherlands, Sweden, Switzerland and the UK,
including teaching hospitals as well as district general hospitals. All
specialities are represented, including Internal Medicine, Obstetrics,
Psychiatry, Surgery, Intensive Care Units and First Aid Stations, with a total
amount of 2.200 beds. Several clinics have recently been classified by
WHO-UNICEF as “Baby-Friendly Hospital”.
Anthroposophic
medicine or anthroposophic medicinal products are legally recognised in the
following States: Austria, Denmark, Finland, Germany, Italy, Sweden,
Switzerland, and United Kingdom. For
further information please contact the respective associations. Anthroposophic
medicinal products are also partly recognised by the European Union.
Anthroposophic
medicine is recognised by the general doctors’ associations in the following
states:
For
further information please contact the respective associations.
Anthroposophic
medicine is taught at universities in Germany, Italy, Switzerland and the United
Kingdom. For
further information please contact the respective associations. International
criteria for a certificate as “anthroposophic doctor” have been established
by the Conference of the Anthroposophical Medical Associations and came into
effect on 18th September 2003. The certificate is issued by the Medical Section
of the School of Spiritual Science at the Goetheanum in Dornach, Switzerland. For
further information please browse:
Research
guidelines for the evaluation of the safety and the efficacy of anthroposophic
medicine are in process. It is aimed to enlarge evidence based methods by
cognition based methods (Kiene 2001). See Fundamental Works in Further
Reading. For
general information, please contact the Research Council of the Medical Section
at the Goetheanum in Dornach, which is chaired by Dr. Peter Heusser: peter.heusser@goetheanum.ch
The
major research institutes are:
Registration
of anthroposophical medicinal products In
European Member States where anthroposophic medicine is well integrated in
society, the anthroposophical medicinal products can benefit from existing
licences and can stay on the national market so far. This is the case in
Germany, Austria and the United Kingdom. In some Member States such as the
Netherlands, Sweden, Belgium, France, Spain and Italy the national agency for
medicinal products for the moment follows a policy of relative tolerance, which
can appear in different forms. In future, European legislation and regulatory
policy will increasingly replace the national legislation and regulatory policy
and is going to create a new situation with threats as well as opportunities for
our medicinal products. Threats as far as manufacturers have difficulties to
demonstrate and document (in the way regulatory authorities want to have it) the
quality, the safety, the effectiveness and the traditional or well-established
medical use of the products, opportunities if it is the other way around. In
general the future European situation will be easier for homoeopathically
manufactured anthroposophic medicinal products than it will be for the
non-homoeopathically manufactured ones. There
will be four different procedures to register or authorise an anthroposophic
medicinal product:
Details
of these procedures can be found in the European legislation as published on the
website of the European Commission http://pharmacos.eudra.org/F2
or on the website of ECHAMP, the European Coalition on Homeopathic and
Anthroposophic Medicinal Products http://www.echamp.org The
evolution from the different tolerant national situations to a more restrictive
European situation has started in 1995 with the implementation of the
homeopathic directive 92/73/EEC. It is very difficult to give a time estimation
of this transition from national legislations to European legislation and
regulatory policy, but it will certainly take at least two decades.
Summary
of the legal situation of anthroposophic medicine in Europe
|
If you have questions, suggestions or comments regarding the content of these pages, please contact directly the secretary of the Medical Section CH-4143 Dornach, Telephone: +41-61-7064290, Telefax: +41-61-7064291, E-mail: med.sektion@goetheanum.ch. This page was updated 08.11.2003. |